𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiosynthesis and bioconjugation of [18F]FPy5yne, a prosthetic group for the 18F labeling of bioactive peptides

✍ Scribed by James A. H. Inkster; Brigitte Guérin; Thomas J. Ruth; Michael J. Adam


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
214 KB
Volume
51
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A new ^18^F‐based prosthetic group has been prepared for the labeling of azide‐modified peptides for use in PET imaging. 2‐[^18^F]fluoro‐3‐(hex‐5‐ynyloxy)pyridine ([^18^F]FPy5yne, [^18^F]‐1) was prepared via efficient nucleophilic heteroaromatic substitution of either the corresponding 2‐nitro (2) or 2‐trimethylammonium trifluoromethanesulfonate pyridine (3). Best radiochemical yield of [^18^F]FPy5yne from 2 was 91% by radioTLC (15 min, 110°C, DMSO). From 3, best radiochemical yield by radioTLC was 93% (15 min, 110°C, MeCN). HPLC‐purified [^18^F]FPy5yne was ligated to model peptide N~3~–(CH~2~)~4~–CO–YKRI–OH by way of Cu^I^‐mediated Huisgen [3+2] cycloaddition in the presence of copper‐stabilizing ligand tris(benzyltriazolylmethyl)amine (TBTA) and N,N‐diisopropylethylamine (DIEA). Bioconjugate radiochemical yields were obtained in average yields of 89%±8.6% (n=4), as judged by radioHPLC. Best non‐decay‐corrected, collected radiochemical yield of modified peptide from end‐of‐bombardment was 5.8% (18.7% decay‐corrected), with a total preparation time of 160 min from start of synthesis. Copyright © 2008 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Reaction of [18F]4-fluorobenzenediazoniu
✍ J. T. Patt; M. Patt 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

## Abstract A reaction route for the preparation of no‐carrier‐added (n.c.a.) [^18^F]S‐4‐fluorophenylcysteine **7** via the [^18^F]‐4‐fluorobenzenediazonium ion **4** is described. The key step in this radiosynthesis is the reaction of **4** with cysteine forming [^18^F]4‐fluorophenyldiazocysteine

A new synthesis of the labeling precurso
✍ Tom C. H. Adamsen; John R. Grierson; Kenneth A. Krohn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB

18 F]-Fluoromisonidazole is the most widely used radiopharmaceutical for imaging hypoxia in tumors. The precursor for [ 18 F]-fluoromisonidazole was prepared from 1,3-dibromo-2propanol in 5 steps from available materials and straightforward purification steps. The overall yield for this synthesis

Automated radiosynthesis of N-(4-[18F]fl
✍ Ingrid Koslowsky; Soraya Shahhosseini; John Wilson; John Mercer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB

## Abstract The potential for radiolabeled antisense oligonucleotides to image gene expression combined with the enhanced resolution of positron‐emission tomography justifies the continued interest in the development of oligonucleotides tagged with positron‐emitting radionuclides. The radiolabeling

In vitro binding profile and radiosynthe
✍ Barbara Wenzel; Achim Hiller; Steffen Fischer; Dietlind Sorger; Winnie Deuther-C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB

## Abstract Radiolabeled vesamicol analogs are promising candidates as ligands for the vesicular acetylcholine transporter (VAChT) to enable __in vivo__ imaging of early cholinergic degenerations in brain. The 4‐fluorobenzoyl‐substituted azaspirovesamicol derivative FBASV is one out of six novel ve

Radiosynthesis of [18F]LBT-999, a select
✍ Frédéric Dollé; Françoise Hinnen; Patrick Emond; Sylvie Mavel; Zoïa Mincheva; Wa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB

LBT-999 (8-((E)-4-fluoro-but-2-enyl)-3b-p-tolyl-8-aza-bicyclo[3.2.1]octane-2b-carboxylic acid methyl ester) is a cocaine derivative belonging to a new generation of highly selective dopamine transporter ligands (K D :9 nM). LBT-999 was labelled with fluorine-18 at its fluoromethylvinyl moiety using

Radiosynthesis of [18F]PBR111, a selecti
✍ Frédéric Dollé; Françoise Hinnen; Annelaure Damont; Bertrand Kuhnast; Christophe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB

## Abstract PBR111 (2‐(6‐chloro‐2‐(4‐(3‐fluoropropoxy)phenyl)imidazo[1,2‐__a__]pyridin‐3‐yl)‐__N__,__N__‐diethylacetamide) is a novel, reported, high‐affinity and selective ligand for the translocator protein (18 kDa). PBR111 has been labelled with fluorine‐18 (half‐life: 109.8 min) using our Zymat